Herpesviruses, as a possible cause complicated course of invasive meningococcal disease (clinical case)
Abstract
About the Authors
N. V. SkripchenkoRussian Federation
Saint-Petersburg
A. A. Vilnits
Russian Federation
Saint-Petersburg
A. S. Drap
Russian Federation
Saint-Petersburg
I. A. Ivashchenko
Russian Federation
Saint-Petersburg
References
1. Lobzin Yu.V., Meningococcal disease in children (epidemiology, clinical features, diagnosis, therapy and prevention): pod red. – Sankt – Peterburg; 2009 (in Russian).
2. Lobzin Y.V., Skripchenko N.V., Vilnits A.A. et al. Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg.// Journal Infectology. 2016;8(1):19-25.
3. Skripchenko N.V., Vilnic A.A., Meningococcal disease in children. Sankt – Peterburg: Taktik-Studio, 2015 (in Russian).
4. Skripchenko, N.V. Analysis and Lessons deaths of meningococcal disease in children. 2009; 4(2): 31–4 (in Russian).// Epidemiologiya i infekcionnye bolezni. – 2009. – № 5. – S. 31–34
5. Deeudom M, Huston W, Moir JW. Lipid-modified azurin of Neisseria meningitidis is a copper protein localized on the outer membrane surface and not regulated by FNR. Antonie Van Leeuwenhoek. 2015 Feb 10.
6. Bhatt N, Khan N, Dash SK, Khare S, Kumar A. nspA gene as a specific genetic marker for detection of Neisseria meningitidis causing bacterial meningitis. Indian J Biochem Biophys. 2014 Jun;51(3):211-4.
7. Emonts M, Vermont CL, Houwing-Duistermaat JJ et al. Polymorphisms in PARP, IL1B, IL4, IL10, C1INH, DEFB1, and DEFA4 in meningococcal disease in three populations. Shock. 2010 Jul;34(1):17-22.
8. Domingo P, Muñiz-Diaz E, Baraldès MA et al. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med. 2002 Jan;112(1):19-25.
9. V.N. Buryak, A.S. Sergienko Associaciya s gerpesvirusami generalizovannyh form meningokokkovoj infekcii //Sovremennaya pediatriya .- 2014.- T.3(59).-S.28-31
10. D. Pace, A.J. Pollard Meningococcal disease: Clinical presentation and sequelae // Vaccine .-2012.-30S.- B3– B9.
11. Sud R, Bhatnagar MK, Sud A, Tiwari A Incidence and outcome of arthritis in meningococcal disease.// J Indian Med Assoc .- 2009.-V. 107 (3).-P.156-159
12. Bhavnagri S, Steele N, Massasso D, Benn R, Youssef P, Bleasel J Meningococcal-associated arthritis: infection versus immune-mediated.// Intern Med J – 2008.-V. 38 (1).-P 71-73
13. Ibrahim KY, Carvalho NB, Moura ML et al. Infection and immune-mediated meningococcal-associated arthritis: combination features in the same patient// Rev. Inst. Med. Trop. Sao Paulo.- 2012.-V 54 (2)
14. Goedvolk CA, von Rosenstiel IA, Bos AP. Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review. //Arch Dis Child.- 2003.-V88(10).-P 927–930.
15. Grumach AS, Kirschfink M. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol. 2014 Oct;61(2):110-7.
Review
For citations:
Skripchenko N.V., Vilnits A.A., Drap A.S., Ivashchenko I.A. Herpesviruses, as a possible cause complicated course of invasive meningococcal disease (clinical case). Journal Infectology. 2016;8(2):105-108. (In Russ.)